A Study to Test Trametinib and dabrafenib in Children and Adolescents Subjects with Cancer

Update Il y a 4 ans
Reference: EUCTR2013-003596-35

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To determine the safe and tolerable trametinib dose(s) for chronic continuous daily dosing in pediatric subjects (infants, children, and adolescents) that achieves similar exposures (trough concentration [Ct]) to the recommended adult dose.


Inclusion criteria

  • Children and Adolescents with Cancers Harboring V600 mutations

Links